Breast cancer is the most common cancer among women across the world. In developed countries, recent years have seen dramatic improvements in survival rates for women with this condition, which has been attributed to widespread screening and improved treatment. However, the continued success of such treatment is dependent on a high level adherence, and it is surprisingly common for women with breast cancer to miss doses or stop taking their preventative treatment all together.
This latest report from the Adherence Research Summarized™ series has been published to help healthcare providers and pharma work with patients to overcome the challenges they face while taking preventative breast cancer therapies.
The report includes:
- Findings from leading research scientists in breast cancer
- Insights from a women who’s taken breast cancer treatments for a number of years
- Proven interventions to improve adherence in breast cancer
- Clinical literature review
Atlantis Healthcare specializes in the development and management of integrated, evidence-based patient support and adherence solutions.
For more information visit atlantishealthcare.com.